GlassScriptPhysician profile
Edward Teng
NPI 1386822484
$12,939.31
in general payments reported to CMS, 2019-2025
11 companies · $4,902 in 2025
The $4,902 reported for 2025 was more than what 92% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,458 · 2020: $35.30 · 2021: $95.29 · 2022: $275 · 2023: $3,157 · 2024: $3,016 · 2025: $4,902.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,951 · Consulting Fee: $3,850 · Travel and Lodging: $3,274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,951.47 |
| Consulting Fee | $3,850.00 |
| Travel and Lodging | $3,273.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $9,952.97 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Strattice Reconstructive Tissue Matrix Bps |
| Kci USA, INC. | $1,051.51 | 2019 | |
| Axogen | $705.09 | 2021-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Kls-Martin L.P. | $369.91 | 2019-2025 | |
| Musculoskeletal Transplant Foundation INC. | $183.23 | 2024 | |
| Mentor Worldwide LLC | $157.31 | 2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $156.82 | 2019-2022 | |
| Rti Surgical, INC | $121.61 | 2023 | |
| Polarityte, INC. | $120.00 | 2019 | |
| Integra Lifesciences Corporation | $85.56 | 2022 | |
| Depuy Synthes Sales INC. | $35.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Teng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.